Vaccines, blood, antisera, toxins and cultures in   Finland

Exports In 2022, Finland exported $121M in Vaccines, blood, antisera, toxins and cultures, making it the 39th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 132nd most exported product in Finland. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Finland are: United States ($26.4M), China ($23.9M), Russia ($10.9M), Sweden ($10.6M), and Germany ($8.54M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Finland between 2021 and 2022 were United States ($7.2M), Germany ($3.67M), and France ($3.65M).

Imports In 2022, Finland imported $666M in Vaccines, blood, antisera, toxins and cultures, becoming the 49th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 23rd most imported product in Finland. Finland imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($218M), Switzerland ($95.4M), Belgium ($78.1M), Denmark ($55.4M), and Austria ($32.5M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Finland between 2021 and 2022 were Belgium ($23.8M), Austria ($7.94M), and Poland ($5.45M).